v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenue $ 452 $ 151 $ 832 $ 520
Costs of revenue 174 94 410 340
Gross profit 278 57 422 180
Operating expenses:        
Research and development 573 1,238 937 2,354
General and administrative 2,318 1,415 4,853 2,734
Sales and marketing 273 21 672 41
Grant and contract expenses 2 48 55 99
Total operating expenses 3,166 2,722 6,517 5,228
Loss from operations (2,888) (2,665) (6,095) (5,048)
Other income (expenses):        
Interest expense (2) (14) (14) (27)
Interest income 12 46 34 87
Gain on disposal of equipment 352 327
Change in fair value of derivative liabilities 139 (39) 482 48
Other income, net 33 2 66 3
Total other income, net 182 347 568 438
Net loss before income taxes (2,706) (2,318) (5,527) (4,610)
Provision for income taxes
Net loss (2,706) (2,318) (5,527) (4,610)
Deemed dividend – warrant modification (926) (926)
Net loss attributable to common stockholders $ (3,632) $ (2,318) $ (6,453) $ (4,610)
Net loss per share – basic and diluted        
Basic – net loss $ (0.56) $ (0.91) $ (1.25) $ (2.14)
Basic – deemed dividend – warrant modification (0.19) (0.21)
Basic – attributable to common stockholders (0.75) (0.91) (1.46) (2.14)
Diluted – net loss (0.56) (0.91) (1.25) (2.14)
Diluted – deemed dividend – warrant modification (0.19) (0.21)
Diluted – attributable to common stockholders $ (0.75) $ (0.91) $ (1.46) $ (2.14)
Weighted average common shares outstanding:        
Basic 4,849,080 2,535,120 4,433,861 2,156,032
Diluted 4,849,570 2,535,120 4,434,615 2,156,223
Product [Member]        
Total revenue $ 447 $ 100 $ 747 $ 391
Grant and Contract [Member]        
Total revenue $ 5 $ 51 $ 85 $ 129